TOBAM’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
TOBAM's GILD Position: Q3 2026 in Review
TOBAM opened a new position in Gilead Sciences (GILD) in Q3 2026: 10,748 shares worth $1.6M. The stake represents 0.66% of the portfolio and ranks #33 among its holdings. This is a return to the name: TOBAM previously reported a position in GILD as recently as Q4 2024.
TOBAM first reported a position in GILD in Q4 2014 and has held it in 26 quarters since. The position peaked at $72.3M in Q2 2021. 2,349 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- TOBAM held 10,748 shares of Gilead Sciences worth $1.6M as of Q3 2026.
- Gilead Sciences was a new TOBAM position in Q3 2026.
- Gilead Sciences made up 0.66% of TOBAM's portfolio in Q3 2026, its #33 holding.
- TOBAM first reported a position in Gilead Sciences in Q4 2014 and has held it in 26 quarters since.
- TOBAM's Gilead Sciences position peaked at $72.3M in Q2 2021.
- 2,349 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on TOBAM's 13F filing for Q3 2026, filed 3 Nov 2026.